Skip to main content

Advertisement

SpringerLink
Log in

Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

Hidradenitis suppurativa / acne inversa (HS) is a chronic inflammatory, debilitating skin disorder with a largely unknown etiology. However, many observations such as the typical onset of the disease after puberty, the female predominance, the pre-menstrual flare ups and the improvement during pregnancy suggest a contribution of endocrinological factors to the emergence of the disease. In addition, the reported efficacy of anti-androgen treatment on HS indicates a possible involvement of androgens in the pathogenesis. Furthermore, the common comorbidity with metabolic syndrome points to possible interactions between endocrinological and metabolic alterations in the development of HS. Taking into account the endocrine functions of the human skin, several studies investigated the effects of hormones and the behavior of the pilosebaceous unit in the skin of patients with HS. In this review we describe the current view on the hormonal dysregulation and metabolic syndrome and their role in HS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9–16.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–72.

    Article  CAS  PubMed  Google Scholar 

  3. von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14:389–92.

    Article  PubMed  Google Scholar 

  4. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23:985–98.

    Article  CAS  PubMed  Google Scholar 

  5. Harrison BJ, Read GF, Hughes LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg. 1988;75:972–5.

    Article  CAS  PubMed  Google Scholar 

  6. Mortimer PS, Dawber RP, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed). 1986;292:245–8.

    Article  CAS  Google Scholar 

  7. Harrison BJ, Kumar S, Read GF, Edwards CA, Scanlon MF, Hughes LE. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985;72:1002–4.

    Article  CAS  PubMed  Google Scholar 

  8. Jemec GBE. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol. 1988;119:345–50.

    Article  CAS  PubMed  Google Scholar 

  9. Brunsting HA. Hidradenitis suppurativa; abscess of the apocrine sweat glands: A study of the clinical and pathologic features, with a report of twenty-two cases and a review of the literature. Arch Dermatol Syphilol. 1939;39:108–20.

    Article  Google Scholar 

  10. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J. 2003;9(1):8.

    PubMed  Google Scholar 

  11. Jemec GB, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology. 1997;194:325–8.

    Article  CAS  PubMed  Google Scholar 

  12. Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134:1057–9.

    Article  CAS  PubMed  Google Scholar 

  13. Zouboulis CC. The skin as an endocrine organ. Dermatoendocrinol. 2009;1:250–2.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol. 1991;125:304–8.

    Article  CAS  PubMed  Google Scholar 

  15. Buimer MG, Wobbes T, Klinkenbijl JH, Reijnen MM, Blokx WA. Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa. Am J Dermatopathol. 2015;37:129–32.

    Article  PubMed  Google Scholar 

  16. Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg. 2007;11:125–31.

    Article  CAS  PubMed  Google Scholar 

  17. Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med. 1993;86:729–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Mortimer PS, Dawber RP, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263–8.

    Article  CAS  PubMed  Google Scholar 

  19. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. Br Med J. 1989;298:28–9.

    Article  CAS  Google Scholar 

  20. Orfanos CE, Adler YD, Zouboulis CC. The SAHA syndrome. Horm Res. 2000;54:251–8.

    CAS  PubMed  Google Scholar 

  21. Camacho FM. SAHA syndrome: female androgenetic alopecia and hirsutism. Exp Dermatol. 1999;8:304–5.

    CAS  PubMed  Google Scholar 

  22. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GBE. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619–44.

    Article  CAS  PubMed  Google Scholar 

  23. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. 1999;141:1138–9.

    CAS  PubMed  Google Scholar 

  24. Randhawa HK, Hamilton J, Pope E. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol. 2013;149:732–5.

    Article  PubMed  Google Scholar 

  25. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005;16:75–8.

    Article  CAS  PubMed  Google Scholar 

  26. Lewis F, Messenger AG, Wales JKH. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol. 1993;129:447–8.

    Article  CAS  PubMed  Google Scholar 

  27. Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. 2001;26:501–3.

    Article  CAS  PubMed  Google Scholar 

  28. Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: A 10-year experience. Surgery. 2005;138:734–41.

    Article  PubMed  Google Scholar 

  29. Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014;28:1013–27.

    Article  PubMed  Google Scholar 

  30. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996;34:994–9.

    Article  CAS  PubMed  Google Scholar 

  31. Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam TN, Jemec GBE. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164:1017–22.

    Article  CAS  PubMed  Google Scholar 

  32. Zouboulis CC. Sebaceous cells in monolayer culture. In Vitro Cell Dev Biol. 1992;28:699.

  33. Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones (Athens). 2004;3:9–26.

    Article  Google Scholar 

  34. Zouboulis CC. Die Talgdrüse. Hautarzt. 2010;61:467–77.

    Article  CAS  PubMed  Google Scholar 

  35. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology. 1998;196:21–31.

    Article  CAS  PubMed  Google Scholar 

  36. Proksch E, Feingold KR, Elias PM. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol. 1992;99:216–20.

    Article  CAS  PubMed  Google Scholar 

  37. Cassidy DM, Lee CM, Laker MF, Kealey T. Lipogenesis in isolated human sebaceous glands. FEBS Lett. 1986;200:173–6.

    Article  CAS  PubMed  Google Scholar 

  38. Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, Clawson G. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120:905–14.

    Article  CAS  PubMed  Google Scholar 

  39. Haag M, Hamann T, Kulle AE, Riepe FG, Blatt T, Wenck H, Holterhus PM, Peirano RI. Age and skin site related differences in steroid metabolism in male skin point to a key role of sebocytes in cutaneous hormone metabolism. Dermatoendocrinol. 2012;4:58–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Grino PB, Griffin JE, Wilson JD. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology. 1990;126:1165–72.

    Article  CAS  PubMed  Google Scholar 

  41. Chen W, Zouboulis CC, Fritsch M, Blume-Peytavi U, Kodelja V, Goerdt S, Luu-The V, Orfanos CE. Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells–evidence of its presence in melanocytes. J Invest Dermatol. 1998;110:84–9.

    Article  CAS  PubMed  Google Scholar 

  42. Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K, Kunz S, Buss A, Roewert HJ, Krause M, Lukowsky A, Volk HD, Sterry W, Sabat R. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol. 2011;186:1228–39.

    Article  CAS  PubMed  Google Scholar 

  43. Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7:e31810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Article  Google Scholar 

  45. Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173:1142–55.

    Article  CAS  PubMed  Google Scholar 

  46. Egeberg A, Gislason GH, Hansen PR. Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa. JAMA Dermatol. 2016;152:429–34.

    Article  PubMed  Google Scholar 

  47. Miller IM, Ellervik C, Vinding GR, Zarchi K, Ibler KS, Knudsen KM, Jemec GBE. Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol. 2014;150:1273–80.

    Article  PubMed  Google Scholar 

  48. Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD. Hidradenitis suppurativa and the metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol. 2015;173:464–70.

    Article  CAS  PubMed  Google Scholar 

  49. Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014;70:699–703.

    Article  PubMed  Google Scholar 

  50. Zabel BA, Ohyama T, Zuniga L, Kim JY, Johnston B, Allen SJ, Guido DG, Handel TM, Butcher EC. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol. 2006;34:1106–14.

    Article  CAS  PubMed  Google Scholar 

  51. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007;109:3625–32.

    Article  CAS  PubMed  Google Scholar 

  52. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, Stumvoll M, Fasshauer M. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept. 2009;154:102–6.

    Article  CAS  PubMed  Google Scholar 

  53. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 2009;58:2731–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Danby FW. Turning acne on/off via mTORC1. Exp Dermatol. 2013;22:505–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Arun B, Loffeld A. Long-standing hidradenitis suppurativa treated effectively with metformin. Clin Exp Dermatol. 2009;34:920–1.

    Article  CAS  PubMed  Google Scholar 

  56. Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27:1101–8.

    Article  CAS  PubMed  Google Scholar 

  57. Danby FW. Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol. 2015;73(suppl 1):S52–4.

    Article  PubMed  Google Scholar 

  58. Brown SC, Kazzazi N, Lord PH. Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg. 1986;73:978–80.

    Article  CAS  PubMed  Google Scholar 

  59. Edlich RF, Silloway KA, Rodeheaver GT, Cooper PH. Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. J Emerg Med. 1986;4:369–78.

    Article  CAS  PubMed  Google Scholar 

  60. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61:51–7.

    Article  PubMed  Google Scholar 

  61. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. 2007;117:3979–87.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. ScientificWorldJournal. 2015;2015:479,354.

    Article  Google Scholar 

  63. Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case–control analysis. J Am Acad Dermatol. 2014;71:1144–50.

    Article  PubMed  Google Scholar 

  64. Chalmers RJ, Ead RD, Beck MH, Dewis P, Anderson DC. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J. 1983;287:1346–7.

    Article  CAS  Google Scholar 

  65. Nickle SB, Peterson N, Peterson M. Updated physician’s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol. 2014;7:22–34.

    PubMed  PubMed Central  Google Scholar 

  66. Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164:170–5.

    Article  CAS  PubMed  Google Scholar 

  67. Matusiak Ł, Bieniek A, Szepietowski JC. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol. 2014;171:170–4.

    Article  CAS  PubMed  Google Scholar 

  68. Chow ET, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol. 1992;126:415.

    Article  CAS  PubMed  Google Scholar 

  69. Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol. 1988;19:355–6.

    Article  CAS  PubMed  Google Scholar 

  70. Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis. 2002;69:287–8.

    PubMed  Google Scholar 

  71. Happle R, van de Kerkhof PC, Traupe H. Retinoids in disorders of keratinization: their use in adults. Dermatologica. 1987;1:107–24.

    Article  Google Scholar 

  72. Vahlquist A, Griffiths W. Retinoid therapy in hidradenitis suppurativa - report of a case. Retinoids Today Tom. 1990;18:28–30.

    Google Scholar 

  73. Puri N, Talwar A. A study on the management of hidradenitis suppurativa with retinoids and surgical excision. Indian J Dermatol. 2011;56:650–1.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Verdolini R, Simonacci F, Menon S, Pavlou P, Mannello B. Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age. G Ital Dermatol Venereol. 2015;150:155–62.

    CAS  PubMed  Google Scholar 

  75. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013;66:620–2.

    Article  CAS  PubMed  Google Scholar 

  76. Kelly G, Sweeney CM, Fitzgerald R, O’Keane MP, Kilbane M, Lally A, Tobin AM, McKenna MJ, Kirby B. Vitamin D status in hidradenitis suppurativa. Br J Dermatol. 2014;170:1379–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Auenweg 38, 06847, Dessau, Germany

    Ioannis Karagiannidis, Georgios Nikolakis & Christos C. Zouboulis

  2. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany

    Robert Sabat

  3. Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany

    Robert Sabat

Authors
  1. Ioannis Karagiannidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgios Nikolakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Sabat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christos C. Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christos C. Zouboulis.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karagiannidis, I., Nikolakis, G., Sabat, R. et al. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?. Rev Endocr Metab Disord 17, 335–341 (2016). https://doi.org/10.1007/s11154-016-9366-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-016-9366-z

Keywords

Search

Navigation